Sertraline and Bivalirudin: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Sertraline
No brand names on recordBivalirudin
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
You've been prescribed sertraline (an antidepressant) along with bivalirudin (a blood thinner usually given in the hospital, often during heart procedures). Both can make bleeding more likely, so together they add up. Sertraline makes tiny blood cells called platelets a little less able to form clots, and bivalirudin directly slows clotting. Combined, that means a somewhat higher chance of bruising, nosebleeds, or bleeding.
The good news is that your care team is very aware of this and watches for it closely, especially in the hospital setting. Don't stop either medicine on your own. Just tell your team right away if you notice unusual bruising or bleeding.
Effect: Additive bleeding risk when sertraline is combined with bivalirudin, a direct thrombin inhibitor.
- Mechanism: SSRIs deplete platelet serotonin, impairing platelet aggregation and hemostasis; this adds to bivalirudin's anticoagulant effect. Pharmacodynamic, not CYP-mediated. Neither agent is a prodrug affecting this interaction.
- Direction/magnitude: Increased bleeding risk; epistaxis, ecchymosis, hematoma, petechiae, and rarely major hemorrhage.
- Onset: Delayed. Evidence: Probable (case-control/cohort). Severity: Major.
- Management: Monitor for clinical signs of bleeding, follow appropriate coagulation/hematologic parameters, and counsel the patient. Dose or therapy may be individualized by the care team.
What happens
An increased risk of bleeding
Interaction Deep Dive
If sertraline is administered together with an anticoagulant, watch the patient for indications of heightened bleeding and warn the patient about the elevated bleeding risk.1 Hemostasis depends in part on platelets releasing serotonin. Studies using case-control and cohort designs have demonstrated that taking SSRIs (for example, sertraline) alongside anticoagulants is linked to a greater bleeding risk 231. Using sertraline at the same time as an anticoagulant can heighten the likelihood of bleeding. Among the bleeding events that have been documented are epistaxis, ecchymosis, hematoma, petechiae, and hemorrhages that threaten life 1.
Why it happens (mechanism)
Release of serotonin by platelets; additive effects on hemostasis
How to manage this interaction
This combination can be used with care, and your care team manages it by watching you more closely.
- Keep taking both as prescribed unless your prescriber tells you otherwise.
- Because bivalirudin is typically given in a monitored setting, your team will watch for signs of bleeding and check labs as needed.
- Report right away: unusual bruising, nosebleeds, pink or red urine, black stools, bleeding gums, or any bleeding that won't stop.
- Let your pharmacist and doctor know you take sertraline so they can tailor monitoring and dosing to you.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
4 reports — tap to read
a) A retrospective cohort study (n=234) reported a heightened risk of clinically relevant bleeding (hospital admission attributable to bleeding) among patients treated with warfarin for atrial fibrillation while concurrently receiving SSRI therapy or within 2 weeks after stopping SSRI therapy. Patients with a mean age of 72 +/- 7 years who received warfarin plus SSRI (n=117) were matched to randomly selected patients who received warfarin alone (n=117). The SSRIs included FLUoxetine, citalopram, PARoxetine, sertraline, fluvoxaMINE, or escitalopram. Nine patients had 11 bleeding episodes over 213.9 treatment years in the warfarin plus SSRI group, whereas 10 patients had 14 bleedings over 586.4 treatment years in the warfarin-only group. The corresponding overall bleeding incidences were 51.4 and 23.9 per 1000 treatment years, respectively. The hazard ratio for first bleedings during warfarin plus SSRI treatment was 3.49 (95% CI; 1.37 to 8.91, p=0.009) relative to warfarin alone. The SSRIs involved in patients who bled during concurrent use were sertraline or citalopram. Adding an SSRI was not linked with any change in warfarin dose or INR (p=0.48 and p=0.31 respectively). The study findings may be constrained by prior bleeding events, unknown patient adherence, and the exclusion of clopidogrel, dipyridamol, corticosteroids and anticoagulants other than warfarin from the model 2.
b) A population-based, case-controlled study of new coumarin users (acenocoumarol and phenprocoumon) taking concurrent selective serotonin reuptake inhibitors (SSRIs) found an elevated risk of hospitalization for non-gastrointestinal bleeding. Drawing on national pharmacy and hospitalization records in the Netherlands, investigators identified 1848 cases admitted for abnormal bleeding and compared them with 5818 control subjects who were also taking a coumarin. The median treatment duration in patients was 220 days (range, 1 to 4690 days). Patients on SSRIs had a greater risk of hospitalization for non-gastrointestinal bleeding (adjusted odds ratio (OR) 1.7, 95% confidence interval (CI), 1.1 to 2.5); however, the rate of gastrointestinal bleeding (adjusted OR 0.8, 95% CI, 0.4 to 1.5) did not differ significantly 3.
c) In a non-blinded, randomized, placebo-controlled trial of 12 healthy volunteers, the impact of sertraline on the plasma protein binding of warfarin was evaluated. On days and 32 of the study, all participants were given warfarin 0.75 mg/kg. Starting on day 11, each volunteer was randomized to either the sertraline or placebo group; sertraline was titrated upward from 50 mg/day to 200 mg/day. Prothrombin time was measured before each warfarin dose and at intervals afterward. The investigators concluded that sertraline did not enhance the anticoagulant effects of warfarin to a clinically significant extent, even though sertraline was administered at a higher-than-usual dose 4.
d) Case reports and epidemiological studies (case-control and cohort studies) have shown an association between the use of drugs that interfere with serotonin reuptake and the occurrence of gastrointestinal bleeding. Based on data from published observational studies, exposure to SSRIs, especially in the month before delivery, has been associated with a less than 2-fold increase in the risk of postpartum hemorrhage. Bleeding events linked to SSRIs and SNRIs have ranged from ecchymosis, hematoma, epistaxis, and petechiae to life-threatening hemorrhages 1.
Common questions
Can I take Sertraline and Bivalirudin together?
Sertraline and bivalirudin both raise bleeding risk, so together the risk adds up. Keep taking both as prescribed, watch for any unusual bruising or bleeding, and let your care team know promptly. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Sertraline and Bivalirudin interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "delayed". Effects tend to build up gradually over days to weeks.
How is the Sertraline and Bivalirudin interaction managed?
This combination can be used with care, and your care team manages it by watching you more closely. Keep taking both as prescribed unless your prescriber tells you otherwise. Because bivalirudin is typically given in a monitored setting, your team will watch for signs of bleeding and check labs as needed. Report right away: unusual bruising, nosebleeds, pink or red urine, black stools, bleeding gu… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Sertraline or Bivalirudin need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (4)
- Product Information: ZOLOFT oral tablets, oral solution, sertraline hydrochloride oral tablets, oral solution. Viatris Specialty LLC (per FDA), Morgantown, WV, 2023. DailyMed
- Wallerstedt SM, Gleerup H, Sundstrom A, et al: Risk of clinically relevant bleeding in warfarin-treated patients-influence of SSRI treatment. Pharmacoepidemiol Drug Saf 2009; 18(5):412-416. DOI
- Schalekamp T, Klungel OH, Souverein PC, et al: Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins. Arch Intern Med 2008; 168(2):180-185. PubMed
- Apseloff G, Wilner K, Gerber N, et al: Effect of sertraline on protien binding of warfarin. Clin Pharmacokinet 1997; 32 (suppl. 1):37-42.
Keep reading about Sertraline
Keep reading about Bivalirudin
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist